Maintenance treatment with inhaled ampicillin in patients with cystic fibrosis and lung infection due to methicillin-sensitive Staphylococcus aureus

Arch Bronconeumol. 2012 Oct;48(10):384. doi: 10.1016/j.arbres.2012.04.002. Epub 2012 May 21.
[Article in English, Spanish]
No abstract available

Publication types

  • Letter

MeSH terms

  • Administration, Inhalation
  • Adolescent
  • Adult
  • Ampicillin / administration & dosage
  • Ampicillin / therapeutic use*
  • Anti-Bacterial Agents / administration & dosage
  • Anti-Bacterial Agents / therapeutic use*
  • Child
  • Child, Preschool
  • Chronic Disease
  • Cystic Fibrosis / complications*
  • Disease Susceptibility
  • Drug Evaluation
  • Female
  • Follow-Up Studies
  • Haemophilus Infections / complications
  • Haemophilus parainfluenzae / isolation & purification
  • Hospitalization / statistics & numerical data
  • Humans
  • Male
  • Methicillin-Resistant Staphylococcus aureus / drug effects*
  • Methicillin-Resistant Staphylococcus aureus / isolation & purification
  • Nebulizers and Vaporizers
  • Pneumonia, Bacterial / complications
  • Pneumonia, Staphylococcal / drug therapy*
  • Pneumonia, Staphylococcal / etiology
  • Pneumonia, Staphylococcal / microbiology
  • Retrospective Studies
  • Superinfection / microbiology
  • Young Adult

Substances

  • Anti-Bacterial Agents
  • Ampicillin